The closest safety dataset is the Increlex (mecasermin) clinical program , which followed 71 pediatric patients with severe primary IGFD on twice-daily SubQ rhIGF-1 for a mean of 3.9 years (some patients up to 11.5 years)
It is not intended for human or animal consumption, medical treatment, or diagnostic purposes
Its essential to follow medical advice and not exceed recommended doses
Heres what that means for you: No needles No self-injection Steady delivery over 12 hours Comfortable daily wear More consistent levels compared to single injections You can apply the patch in-office and wear it throughout your day
Anxiety disorders, on the other hand, arise when the degree of anxiety experienced is disproportionate to the threat posed by given circumstances
This fundamental mechanism underpins its efficacy in repairing a wide array of tissues, from gut mucosa and muscle tendons to neural tissue